Medical Castration with Zoladex: A Conservative Approach to Premenopausal Breast Cancer

@article{Brambilla1991MedicalCW,
  title={Medical Castration with Zoladex: A Conservative Approach to Premenopausal Breast Cancer},
  author={C. Brambilla and A. Escobedo and R. Artioli and M. Lechuga and M. Motta and G. Bonadonna},
  journal={Tumori Journal},
  year={1991},
  volume={77},
  pages={145 - 150}
}
  • C. Brambilla, A. Escobedo, +3 authors G. Bonadonna
  • Published 1991
  • Medicine
  • Tumori Journal
  • For almost a century surgical castration represented the initial standard therapy for metastatic breast cancer in premenopausal women with hormone dependent tumors. Today the suppression of ovarian function can also be obtained by the administration of supraphysiologic doses of luteinizing hormone releasing hormone (LHRH) agonists. From April 1987 to February 1989, 23 premenopausal patients with advanced breast cancer (median age 39 years, range 28-52, ER positive 20, unknown 3; prior… CONTINUE READING
    12 Citations
    Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study.
    • C. Taylor, S. Green, +10 authors C. Osborne
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 1998
    • 188
    Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: results of a multicentric Italian study.
    • 132
    Phase II study of goserelin for patients with postmenopausal metastatic breast cancer.
    • T. Saphner, A. Troxel, +6 authors M. Abeloff
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 1993
    • 20
    Endocrinological and clinical evaluation of two depot formulations of leuprolide acetate in pre- and perimenopausal breast cancer patients
    • 9
    Successful co‐treatment with LHRH‐agonist for ovarian over‐stimulation and cystic formation in premenopausal tamoxifen exposure
    • 21
    • Highly Influenced
    Management of metastatic breast cancer
    • 22
    Endocrine therapy for advanced breast cancer.
    • 11
    • PDF
    Laparoscopic oophorectomy: a prospective evaluation in pre-menopausal breast cancer with particular reference to incidence and severity of menopausal symptoms.
    • 1

    References

    SHOWING 1-10 OF 30 REFERENCES
    Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group.
    • M. Kaufmann, W. Jonat, +7 authors H. Schmid
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 1989
    • 106
    Medical castration produced by the GnRH analogue leuprolide to treat metastatic breast cancer.
    • 61
    Salvage treatments in relapsing resectable breast cancer.
    • 19
    Endocrine therapy of breast cancer.
    • 28